We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Allosterism of Nicotinic Acetylcholine Receptors: Therapeutic Potential for Neuroinflammation Underlying Brain Trauma and Degenerative Disorders.
- Authors
Mitra, Swarup; Khatri, Shailesh N.; Maulik, Malabika; Bult-Ito, Abel; Schulte, Marvin
- Abstract
Inflammation is a key physiological phenomenon that can be pervasive when dysregulated. Persistent chronic inflammation precedes several pathophysiological conditions forming one of the critical cellular homeostatic checkpoints. With a steady global surge in inflammatory diseases, it is imperative to delineate underlying mechanisms and design suitable drug molecules targeting the cellular partners that mediate and regulate inflammation. Nicotinic acetylcholine receptors have a confirmed role in influencing inflammatory pathways and have been a subject of scientific scrutiny underlying drug development in recent years. Drugs designed to target allosteric sites on the nicotinic acetylcholine receptors present a unique opportunity to unravel the role of the cholinergic system in regulating and restoring inflammatory homeostasis. Such a therapeutic approach holds promise in treating several inflammatory conditions and diseases with inflammation as an underlying pathology. Here, we briefly describe the potential of cholinergic allosterism and some allosteric modulators as a promising therapeutic option for the treatment of neuroinflammation.
- Subjects
NICOTINIC acetylcholine receptors; BRAIN degeneration; CHOLINERGIC receptors; INFLAMMATION; ALLOSTERIC regulation; DRUG design; NICOTINIC receptors; CONOTOXINS
- Publication
International Journal of Molecular Sciences, 2020, Vol 21, Issue 14, p4918
- ISSN
1661-6596
- Publication type
Article
- DOI
10.3390/ijms21144918